1 / 27

Application for Initial Reviews

Application for Initial Reviews. Human Subject Protection Office UConn Health Center Judy Gaffney, BA Monika Haugstetter, MHA, RN, MSN. http://resadm.uchc.edu/hspo/index.html.

vevina
Download Presentation

Application for Initial Reviews

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Applicationfor Initial Reviews Human Subject Protection Office UConn Health Center Judy Gaffney, BA Monika Haugstetter, MHA, RN, MSN http://resadm.uchc.edu/hspo/index.html

  2. All applicationsmustbe typed. Point, click and type in the appropriate cell. Cells will expand to accommodate text. Tabbing out of the last cell on the right of a table will insert another row. Referencing the protocol is not acceptable since not all IRB members receive the complete protocol. The IRB reserves the right to return applications that do not provide sufficient responses. When submitting for continuing review the application must reflect the currently approved status of the study. For example, if inclusion / exclusion criteria were changed via a request for modification the application must reflect that approved change. For continuations the Addendum to the Application to Request Continuing Review must be appended to this form. Any modifications being proposed with the continuation are to be noted on that form in the proposed modification section. http://resadm.uchc.edu/hspo/index.html

  3. NOTES: If you will be applying to the General Clinical Research Center to provide support for this study you must also submit this application and supporting documents electronically to Lisa Godin for review and approval by the GCRC. Investigators may apply to the GCRC prior to or concurrent with the IRB submission. For question related to GCRC submission contact Lisa Godin at 679-4145, or godin@uchc.edu. For complete direction for GCRC submission refer to the application instructions. If you are requesting approval for a Humanitarian Use Device, use the application specific to HUDs. If you are requesting approval for a registry/repository use the application specific to registry/repositories. If the study involves the use of Recombinant DNA or gene therapy you must first obtain approval from the Institutional Biosafety Committee. Refer to the complete and detailed instructions for specific questions to ensure that all elements are adequately addressed. You may print the document in color or in grayscale. http://resadm.uchc.edu/hspo/index.html

  4. http://resadm.uchc.edu/hspo/index.html

  5. http://resadm.uchc.edu/hspo/index.html

  6. http://resadm.uchc.edu/hspo/index.html

  7. 3.2Indicate the expected percentage of enrollment at each applicable site, and place an X in the appropriate cell to indicate which institution, based on the preponderance of the expected enrollment, you are requesting serve as the IRB of record or that independent IRB approval will be sought from each applicable site.

  8. 4.0Provide the anticipated time frame during which the study will be conducted: 4.2 Place an X after the applicable study phase: 4.4Place an X after all characteristics that are applicable to the studydesign: http://resadm.uchc.edu/hspo/index.html

  9. 4.7Provide either a flow diagram or outline of the experimental design addressing the elements noted below. ( http://resadm.uchc.edu/hspo/index.html

  10. http://resadm.uchc.edu/hspo/index.html

  11. http://resadm.uchc.edu/hspo/index.html

  12. http://resadm.uchc.edu/hspo/index.html

  13. 5.6 http://resadm.uchc.edu/hspo/index.html

  14. http://resadm.uchc.edu/hspo/index.html

  15. http://resadm.uchc.edu/hspo/index.html

  16. http://resadm.uchc.edu/hspo/index.html

  17. Pregnant Womenor Fetuses (B204 or B207) Children/Adolescents (D404, D405, D406 or D407) Prisoners (C ) Neonates of uncertain viability or non-viable (B205 or B207) Decisionally Impaired (S and (D404, D405, D406 or D407)) UCHC Inpatients- Including Prisoners (C ) Abortuses (B206 or B207) Viable Neonates (D404, D405, D406 or D407) UCHC Inpatients–No Prisoners UCHC Employees (S) Educationally Disadvantaged (S) Outpatients UCHC Students (S) Economically Disadvantaged (S) Terminally Ill (S) Other (describe) http://resadm.uchc.edu/hspo/index.html

  18. http://resadm.uchc.edu/hspo/index.html

  19. Methods/Materials X to Select Description of Implementation Closed to enrollment Radio spots Newspapers Magazines Broadcast messages Purchased mailing lists Patient base Flyers Proband Phone Calls Web postings* Other methods, materials and strategies that will be used for subject recruitment(provide description): http://resadm.uchc.edu/hspo/index.html

  20. http://resadm.uchc.edu/hspo/index.html

  21. http://resadm.uchc.edu/hspo/index.html

  22. http://resadm.uchc.edu/hspo/index.html

  23. http://resadm.uchc.edu/hspo/index.html

  24. http://resadm.uchc.edu/hspo/index.html

More Related